Show newer

Check out the latest paper from my buddy @TheVilchezLab on aging. The third paper today from my smart friends! V r doing well.
---
RT @TheVilchezLab
New work from the lab @NatureAging!❄️Lowering body temperature extends #longevity. We find that cold-induced #proteostasis prevents #aging and aggregation of proteins that cause age-related diseases #ALS #HuntingtonDisease in C. elegans and human cells nature.com/articles/s43…
twitter.com/TheVilchezLab/stat

"Thus, we performed a comprehensive screen of TE-chimeric transcripts across 10,357 tumors, 675 cancer cell lines and 11,686 Genotype-Tissue Expression (GTEx) adult tissues, and evaluated these TE-chimeric candidates for tumor specificity, antigenic potential, proteomic validation, HLA presentation and membrane presence."

nature.com/articles/s41588-023

"These differences in expression necessarily limit the usefulness of these systems in identifying and understanding the more subtle roles played by ACE2 in the development and resolution of COVID-19. To overcome these limitations, we have developed two mouse lines in which the ACE2 locus has been humanized by syntenic replacement."


journals.plos.org/plospathogen

'It is hoped that a spatially resolved picture of protein expression, posttranslational protein modifications, cell phenotypes, and communities of cell phenotypes will not only advance our understanding of tumor evolution (3) but also guide patient treatment response prediction modeling and the development of novel cancer therapeutics targeting the TME, such as bispecific T-cell engagers, immune-checkpoint inhibitors (ICI), and chimeric antigen receptor (CAR) T cells.'

aacrjournals.org/cancerdiscove

"Two concurrent outbreaks of the Marburg virus, a close cousin of Ebola that can kill as many as 90 percent of the people it infects, are raising critical questions about the behavior of this mysterious bat-borne pathogen and global efforts to prepare for potential pandemics."

nytimes.com/2023/04/03/health/

Nobelist Martin Chalfie on how *not* to apply for a postdoc:

"They say 'Here is my CV and I'd really like to work in your lab, do you have any space? That's a letter that could be sent out to a hundred people, or a thousand people. There's nothing in it."

youtube.com/watch?v=x2fBwH6Cup

RT @Lo_Zanzi
Excited for our collaboration @naturemethods with @slavov_n: a new prioritized #SingleCell #MassSpec approach to increase proteome depth, reducing time, in our beloved #macrophages! We identified endocytic & proteolitic differences at the single cell lvl! doi.org/10.1038/s41592-023-018

"The Federal Trade Commission has ordered Illumina to divest cancer screening company Grail, arguing the $8bn acquisition would damage competition in the US market for life-saving cancer tests."

ft.com/content/3848cf02-8d00-4

For some time now, I've collected quotes from authors, filmmakers, musicians, fine artists, and more about art, creative process, inspiration, and much more. This one ponders the question:

WHY DO WE CREATE?

Maybe something in here will help you…

Read here: medium.com/@cole.haddon/the-ar

#writing #amwriting #writingcommunity #screenwriting #filmmaking #art #author #music #inspiration #creativity #creativewriting

RT @robinsall
A short thread about Adam Dowdell's excellent chemotaxis paper, just out in @CurrentBiology. It shows how combinations of ligands for the same receptors cause fascinating & counterintuitive outcomes (1/n)
cell.com/current-biology/fullt

"The prolific chemist, who has published a study every 37 hours this year, has been sanctioned by the University of Córdoba over his research work for other institutions in Russia and Saudi Arabia"

english.elpais.com/science-tec

... and that's a damn shame.

'The only contemporary setting in which small research groups really seem to have a fighting chance at the cutting edge is when they’re (i) extremely well-funded with (ii) access to state-of-the-art core facilities in (iii) an intellectually lively environment and (iv) little to no teaching hours attached. That kind of setting is vanishingly rare.'
@TIR_scienceblog

totalinternalreflectionblog.co

'Ben Barres Early Career Acceleration Awards. This is an investigator award for early career academic investigators, especially those who are new to the field of neurodegeneration. Awards are $1.2M in total costs over 4 years. Early career investigators will benefit from mentored support and resources of the CZI Neurodegeneration Challenge Network.'

chanzuckerberg.com/rfa/ben-bar

Another bonehead #Musk move: "#Twitter has stopped officially distinguishing between legacy verified users and accounts that pay for Twitter Blue."
theverge.com/2023/4/3/23667751

Why would anyone pay for a blue checkmark when it might only prove that you paid for it?

If it formerly verified your identify, why would you continue to pay for it?

I feel sorry for the legacy verified users who are now tainted with the suspicion that they merely paid to appear verified.

🚨 Want to find out about latest developments in Infectious Diseases from a stellar lineup of experts? 🦠🧫🦟

Then do join us for a new 1-day meeting Fri 19th May ✏️

Both in-person & virtual attendance options. For more info & to book place 👇
uclinfectioncourses.wordpress.

#IDMastodon #MedMastodon #AMR #antibiotics #microbiology #academia #infections #virology

RT @TrainingVbc
Today, we are featuring the Stem Cells, Dev. & Regeneration groups that have open positions in the Vienna BioCenter PhD Program Spring call is open until 8 April. bit.ly/3YYvA38 @IMPvienna @IMBA_Vienna @gmivienna @maxperutzlabs @univienna @MedUni_Wien #PhDprogram

RT @ouvrirlascience
Candidatez pour le prix #scienceouverte du #logiciellibre de la recherche 2023 jusqu'au 15 mai 2023 !
Partagez largement cette information et invitez les projets logiciels de votre entourage à candidater !
bit.ly/40TOyZv

The ISID & ESCMID fellowship program is accepting applications! Seeking early-career investigators from #LMICs interested in traveling to Europe for multidisciplinary clinical and laboratory training.

Submission ends on June 16, 2023 at 12pm (EST)
ow.ly/B9c450Nyymv

Show older
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.